CME Group (NASDAQ:CME) 주식

CME GROUP INC

CME Group

CME Gr

Based in Chicago, CME Group operates exchanges giving investors, suppliers, and businesses the ability to trade futures and derivatives based on interest rates, equity indexes, foreign currencies, energy, metals, and commodities. The Chicago Mercantile Exchange was founded in 1898 and in 2002 completed its IPO. Since then, CME Group has consolidated parts of the industry by merging with crosstown rival CBOT Holdings in 2007 before acquiring Nymex Holdings in 2008 and NEX in 2018. In addition, the company has a 27% stake in S&P Dow Jones Indices, making the Chicago Mercantile Exchange the exclusive venue to trade and clear S&P futures contracts. Through CME's acquisition of NEX, it also expanded into cash foreign exchange, fixed-income trading, and collateral optimization.

Japan.Flag.Stockmarket.Shutterstock

Global

General

AAPL

DELL

NVDA

연방준비제도(연준)가 기준 금리를 25bp(베이시스 포인트) 인하할지, 50bp 인하할지는 수요일 회의 전에 가장 큰 관심사이다. 하지만 대답해야 할 &#39;더 큰 질문&#39;이 있다고 그레이트 힐 캐피털(Great Hill Capital)의 토마스 헤이즈(Thomas Hayes)가 벤징가(Benzinga)에 말했다.

연준이 금리 인하에 나서는 동안, 한 헤지 펀드는 더 큰 촉매제인 일본 중앙은행에 주목

Tesla's Sky-High Surge

Equities

News

Previews

Tech

Trading Ideas

ABBV

AGYS

ASML

BJRI

CHKP

CHTR

CMCSA

DECK

GATX

GOOG

GOOGL

JNPR

NFLX

NXPI

ODFL

ORLY

SKYW

SPOT

TSLA

VRSN

S&amp;P 500 기업들 중 약 14%가 6월 분기 실적을 발표했으며, 더 넓은 지수를 구성하는 기업들의 혼합 실적 성장률은 여전히 ​​양호하다. 이번 주에는 기술 보고 시즌이 공식적으로 시작될 것이며, 이는 최근 주에 가파른 하락세를 보인 시장의 향방을 잠재적으로 결정할 수 있다.

테슬라, 알파벳, GM 및 포드가 이번 주 실적 발표 주도하며 상승세 유지 위해 고군분투

CME Group Inc

COMPUTER ENGNR&CONSLTNG by Computer Engineering & Consulting Ltd

Computer Engineering & Consulting Ltd

CHINA MEIDONG AUTO HLDGS by China Meidong Auto Hldgs

China MeiDong Auto Holdings Ltd

CM ENERGY TECH CO LTD by CM ENERGY TECH CO LTD

CM Energy Tech Co Ltd

CREO MED GROUP LTD by CREO MED GROUP LTD.

Creo Medical Group PLC

CoinMerge (BEP-20)

CMONEY INC by cMoney, Inc.

As of April 4, 2025, three stocks in the financial sector could be flashing a real warning to investors who value momentum as a key criteria in their trading decisions.
The RSI is a momentum indicator, which compares a stock&#8217;s strength on days when prices go up to its strength on days when prices go down. When compared to a stock&#8217;s price action, it can give traders a better sense of how a stock may perform in the short term. An asset is typically considered overbought when the <a href="https://www.benzinga.com/topic/rsi">RSI is above 70</a>, according to <a href="https://pro.benzinga.com/">Benzinga Pro</a>. 
Here's the latest list of major overbought players in this sector.
<h3 class="wp-block-heading">Heritage Insurance Holdings Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HRTG#NYSE">HRTG</a>)</h3>
<ul>
<li>On March 11, Heritage Insurance posted better-than-expected quarterly earnings. &#8220;The year 2024 was marked by numerous destructive hurricanes affecting communities across the Southeastern United States and in 2025, we&#8217;ve seen devastating wildfires affect residents of California,&#8221; said Ernie Garateix, Heritage CEO. The company's stock gained around 35% over the past month and has a 52-week high of $16.90.</li>
<li>RSI Value: 75.3&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</li>
<li>HRTG Price Action: Shares of Heritage Insurance gained 0.6% to close at $15.62 on Thursday.</li>
<li>Edge Stock Ratings: 94.40 Momentum score with Value at 91.39. </li>
</ul>
<figure class="wp-block-image size-full"><a href="https://www.benzinga.com/quote/HRTG"><img loading="lazy" decoding="async" width="432" height="178" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/04042734/image-42.png" alt="" class="wp-image-857066" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/04042734/image-42.png 432w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/04042734/image-42-300x124.png 300w" sizes="(max-width: 432px) 100vw, 432px" /></a></figure>
<h3 class="wp-block-heading">CME Group Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CME#NASDAQ">CME</a>)</h3>
<ul>
<li>On April 2, CME Group reported that average daily volume rose 13% year-over-year in the first quarter. The company's stock gained around 7% over the past month and <a href="https://www.benzinga.com/quote/CME">has a 52-week high</a> of $271.22.</li>
<li>RSI Value: 71.4</li>
<li>CME Price Action: Shares of CME gained 2.2% to close at $268.36 on Thursday.</li>
</ul>
<h3 class="wp-block-heading">EZCORP Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EZPW#NASDAQ">EZPW</a>)</h3>
<ul>
<li>On March 28, EZCORP announced the closing of private offering of $300,000,000 of senior notes due 2032. The company's stock gained around 19% over the past month and has a<a href="https://www.benzinga.com/quote/EZPW"> 52-week high</a> of $16.35.</li>
<li>RSI Value: 76.5</li>
<li>EZPW Price Action: Shares of EZCORP gained 3% to close at $15.78 on Thursday.</li>
</ul>
Curious about other BZ Edge Rankings? Click here to discover <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-2#:~:text=Turn%20Market%20Chaos,when%20markets%20rebound">how similar stocks measure up</a>. 
Read This Next: 
<ul>
<li><a href="https://www.benzinga.com/25/04/44641655/guess-simulations-plus-and-3-stocks-to-watch-heading-into-friday">Guess, Simulations Plus And 3 Stocks To Watch Heading Into Friday</a> </li>
</ul>
Photo via Shutterstock

Short Ideas

Pre-Market Outlook

Markets

EZPW

HRTG

Top 3 Financial Stocks That May Fall Off A Cliff In April

RBC Capital analyst Ashish Sabadra reiterates CME Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CME#NASDAQ">CME</a>) with a Sector Perform and maintains $269 price target.

Price Target

Reiteration

Analyst Ratings

RBC Capital Reiterates Sector Perform on CME Group, Maintains $269 Price Target

Macro uncertainty has delayed the timeline for an IPO comeback, but there remains substantial pent-up supply for equity issuance.
That&#8217;s according to BofA Securities analyst Craig Siegenthaler, who <a href="https://www.benzinga.com/topic/exchanges" target="_blank" rel="noreferrer noopener">maintained all of his</a> ratings and continues to look for a reopening in the second half of 2025. 
This will restart Nasdaq, Inc&#8216;s (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NDAQ#NASDAQ">NDAQ</a>) strategic flywheel across listings, trading, and corporate services, he says.
Also Read: <a href="https://www.benzinga.com/government/regulations/25/03/44190371/nasdaq-plans-24-hour-trading-to-tap-global-investor-demand" target="_blank" rel="noreferrer noopener">Nasdaq Plans 24-Hour Trading To Tap Global Investor Demand</a>
Siegenthaler continued to forecast the highest 12-month upside for: 
<ul>
<li>Tradeweb Markets Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TW#NASDAQ">TW</a>); Buy rating, price target $212 from $197.</li>
<li>BGC Group, Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BGC#NASDAQ">BGC</a>); Buy rating, price target $15 from $16.</li>
<li>Nasdaq; Buy rating, price target $105 from $103.</li>
<li>Cboe Global Markets, Inc (BATS:<a class="ticker" href="https://www.benzinga.com/stock/CBOE#BATS">CBOE</a>); Buy rating, price target $260 from $251.</li>
</ul>
There is a significant runway left in the electronification of fixed-income markets at Tradeweb Markets, and given their considerable rates business, the analyst noted that Tradeweb Markets will capitalize on the political uncertainty in Washington.
Siegenthaler will look for BGC Group to launch Treasury futures within days and expect their share of the $2 billion revenue per year interest rate futures market to continue accelerating, surpassing 10% in 2027.
The increasingly uncertain macroeconomic and geopolitical backdrop produced ideal conditions for trading across asset classes. 
Accordingly, Siegenthaler raised EPS for his entire market structure coverage. While the analyst expects some downward normalization in volumes into the second half of 2025 (in parallel with a pickup in IPOs), ongoing geopolitical uncertainty will remain an important trading catalyst.
Given his view of second-half normalizations, we are less bullish on Exchange stocks (which outperformed) than the Alts and Brokers.
With market structure stocks up 8% on average in the first quarter of 2025, Nasdaq and Virtu Financial, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VIRT#NASDAQ">VIRT</a>) — Buy rating, price target $48 from $56 — have lagged the group.
Nevertheless, the analyst forecasted over 10% first-quarter 2025 EPS beats for both stocks.
Both companies have benefitted from the surge in equity volume in the first quarter of 2025.
Assets under management linked to the Nasdaq-100 have faced beta headwinds related to the choppy equity markets year-to-date. One-third of their indexing revenue is derived from Nasdaq-100 futures, which posted their strongest growth quarter in years (up 38% sequentially) and are seeing strong adoption at the online brokers. In addition, the annual listing price hike (estimated 5%) should more than offset any delisting headwinds. 
Meanwhile, Virtu Financial should also see solid results across its organic initiatives, with industry volumes in options, ETFs, and fixed income higher sequentially.
MarketAxess Holdings, Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MKTX#NASDAQ">MKTX</a>) — Underperform rating, price target $191 from $189 — rallied 12% in March. 
Investors embedded an industrywide mix shift into A2A RFQ, where they are dominant. Siegenthaler noted that portfolio trading (PT) and D2D trading have also logged impressive volumes month-to-date, up 18% and 11% month-on-month (versus +9% for TRACE).
Tradeweb Markets remains dominant in both of these market segments. Accordingly, the analyst does not expect MarketAxess Holdings to post higher market share gains than Tradeweb Markets in March. Meanwhile, Intercontinental Exchange Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ICE#NYSE">ICE</a>) — Buy rating, price target $230 from $237 — will likely experience near-term cyclical headwinds in its mortgage and listing business.
Cboe Global Markets, Inc (BATS:<a class="ticker" href="https://www.benzinga.com/stock/CBOE#BATS">CBOE</a>) — Buy rating, price target $260 from $251 — and Tradeweb Markets could see a sequentially adverse product mix shift, given a lower contribution from SPX and muni bonds. 
Futures and index options usage CME Group Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CME#NASDAQ">CME</a>) — Underperform rating, price target $219 from $200 — and Cboe Global Markets on Robinhood is ramping nicely. La Nina has been a helpful catalyst for commodity futures. The Mr. Cooper and Rocket Mortgage deal will cost Intercontinental Exchange approximately 410 bps of servicing share and 130 bps of origination share, which the analyst noted amounts to a $72 million headwind.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/media/25/04/44608574/chip-giants-arm-qualcomm-target-alphawave-to-capture-ai-success-like-broadcom" target="_blank" rel="noreferrer noopener">Chip Giants Arm, Qualcomm Target Alphawave To Capture AI Success Like Broadcom</a></li>
</ul>
Image: Shutterstock

IPOs

CBOE

MKTX

NDAQ

VIRT

Tradeweb, Nasdaq, Virtu, ICE, BGC Group, Cboe Set To Benefit From IPO Comeback: Analyst

Throughout the last three months, 12 analysts have evaluated CME Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CME#NASDAQ">CME</a>), offering a diverse set of opinions from bullish to bearish.
In the table below, you'll find a summary of their recent ratings, revealing the shifting sentiments over the past 30 days and comparing them to the previous months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">0</td>
<td align="right">3</td>
<td align="right">7</td>
<td align="right">2</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">4</td>
<td align="right">1</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">3</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
Analysts have recently evaluated CME Group and provided 12-month price targets. The average target is $253.17, accompanied by a high estimate of $287.00 and a low estimate of $212.00. This upward trend is evident, with the current average reflecting a 4.26% increase from the previous average price target of $242.82.
<img src="https://www.benzinga.com/files/images/story/2025/1743616883_0.png" alt="price target chart" />
<h2>Understanding Analyst Ratings: A Comprehensive Breakdown</h2>
The perception of CME Group by financial experts is analyzed through recent analyst actions. The following summary presents key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Craig Siegenthaler</td>
<td>B of A Securities</td>
<td>Raises</td>
<td>Underperform</td>
<td>$219.00</td>
<td>$200.00</td>
</tr>
<tr>
<td>Patrick O'Shaughnessy</td>
<td>Raymond James</td>
<td>Announces</td>
<td>Outperform</td>
<td>$287.00</td>
<td>-</td>
</tr>
<tr>
<td>Mike Cyprys</td>
<td>Morgan Stanley</td>
<td>Raises</td>
<td>Equal-Weight</td>
<td>$263.00</td>
<td>$256.00</td>
</tr>
<tr>
<td>Kyle Voigt</td>
<td>Keefe, Bruyette &amp; Woods</td>
<td>Raises</td>
<td>Market Perform</td>
<td>$257.00</td>
<td>$256.00</td>
</tr>
<tr>
<td>Ashish Sabadra</td>
<td>RBC Capital</td>
<td>Raises</td>
<td>Sector Perform</td>
<td>$269.00</td>
<td>$235.00</td>
</tr>
<tr>
<td>Owen Lau</td>
<td>Oppenheimer</td>
<td>Raises</td>
<td>Outperform</td>
<td>$269.00</td>
<td>$258.00</td>
</tr>
<tr>
<td>Kenneth Worthington</td>
<td>JP Morgan</td>
<td>Raises</td>
<td>Underweight</td>
<td>$212.00</td>
<td>$209.00</td>
</tr>
<tr>
<td>Benjamin Budish</td>
<td>Barclays</td>
<td>Raises</td>
<td>Equal-Weight</td>
<td>$263.00</td>
<td>$257.00</td>
</tr>
<tr>
<td>Kyle Voigt</td>
<td>Keefe, Bruyette &amp; Woods</td>
<td>Lowers</td>
<td>Market Perform</td>
<td>$256.00</td>
<td>$260.00</td>
</tr>
<tr>
<td>Patrick Moley</td>
<td>Piper Sandler</td>
<td>Raises</td>
<td>Overweight</td>
<td>$258.00</td>
<td>$250.00</td>
</tr>
<tr>
<td>Ashish Sabadra</td>
<td>RBC Capital</td>
<td>Maintains</td>
<td>Sector Perform</td>
<td>$235.00</td>
<td>$235.00</td>
</tr>
<tr>
<td>Christopher Allen</td>
<td>Citigroup</td>
<td>Lowers</td>
<td>Neutral</td>
<td>$250.00</td>
<td>$255.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Analysts frequently update their recommendations based on evolving market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to CME Group. This information provides a snapshot of how analysts perceive the current state of the company.</li>
<li>Rating: Offering insights into predictions, analysts assign qualitative values, from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of CME Group compared to the broader market.</li>
<li>Price Targets: Analysts gauge the dynamics of price targets, providing estimates for the future value of CME Group's stock. This comparison reveals trends in analysts' expectations over time.</li>
</ul>
Analyzing these analyst evaluations alongside relevant financial metrics can provide a comprehensive view of CME Group's market position. Stay informed and make data-driven decisions with the assistance of our Ratings Table.
<a href="https://www.benzinga.com/quote/CME/analyst-ratings?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Stay up to date on CME Group analyst ratings.</a>
<h2>Get to Know CME Group Better</h2>
Based in Chicago, CME Group operates exchanges giving investors, suppliers, and businesses the ability to trade futures and derivatives based on interest rates, equity indexes, foreign currencies, energy, metals, and commodities. The Chicago Mercantile Exchange was founded in 1898 and in 2002 completed its IPO. Since then, CME Group has consolidated parts of the industry by merging with crosstown rival CBOT Holdings in 2007 before acquiring Nymex Holdings in 2008 and NEX in 2018. In addition, the company has a 27% stake in S&amp;P Dow Jones Indices, making the Chicago Mercantile Exchange the exclusive venue to trade and clear S&amp;P futures contracts. Through CME's acquisition of NEX, it also expanded into cash foreign exchange, fixed-income trading, and collateral optimization.
<h3>CME Group: Financial Performance Dissected</h3>
Market Capitalization Analysis: Above industry benchmarks, the company's market capitalization emphasizes a noteworthy size, indicative of a strong market presence.
Revenue Growth: CME Group's revenue growth over a period of 3 months has been noteworthy. As of 31 December, 2024, the company achieved a revenue growth rate of approximately 5.98%. This indicates a substantial increase in the company's top-line earnings. As compared to its peers, the revenue growth lags behind its industry peers. The company achieved a growth rate lower than the average among peers in Financials sector.
Net Margin: CME Group's net margin excels beyond industry benchmarks, reaching 56.62%. This signifies efficient cost management and strong financial health.
Return on Equity (ROE): CME Group's ROE stands out, surpassing industry averages. With an impressive ROE of 3.16%, the company demonstrates effective use of equity capital and strong financial performance.
Return on Assets (ROA): CME Group's ROA lags behind industry averages, suggesting challenges in maximizing returns from its assets. With an ROA of 0.63%, the company may face hurdles in achieving optimal financial performance.
Debt Management: The company maintains a balanced debt approach with a debt-to-equity ratio below industry norms, standing at 0.13.
<h2>Analyst Ratings: Simplified</h2>
Ratings come from analysts, or specialists within banking and financial systems that report for specific stocks or defined sectors (typically once per quarter for each stock). Analysts usually derive their information from company conference calls and meetings, financial statements, and conversations with important insiders to reach their decisions.
Some analysts also offer predictions for helpful metrics such as earnings, revenue, and growth estimates to provide further guidance as to what to do with certain tickers. It is important to keep in mind that while stock and sector analysts are specialists, they are also human and can only forecast their beliefs to traders.
Which Stocks Are Analysts Recommending Now?
Benzinga Edge gives you instant access to all major analyst upgrades, downgrades, and price targets. Sort by accuracy, upside potential, and more. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=be8be9arja3be22bz21&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Click here to stay ahead of the market</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

12 Analysts Have This To Say About CME Group

B of A Securities analyst Craig Siegenthaler maintains CME Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CME#NASDAQ">CME</a>) with a Underperform and raises the price target from $200 to $219.

B of A Securities Maintains Underperform on CME Group, Raises Price Target to $219

CME Group Q1 Average Daily Volume Up 13% YoY, March ADV Up 27% YoY

CME Group's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CME#NYSE">CME</a>) short percent of float has risen 9.29% since its last report. The company recently reported that it has 5.51 million shares sold short, which is 1.53% of all regular shares that are available for trading. Based on its trading volume, it would take traders 1.85 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">List of the most shorted stocks</a>
<h3>CME Group Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1743181232_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for CME Group has grown since its last report. This does not mean that the stock is going to fall in the near-term but traders should be aware that more shares are being shorted.
<h3>Comparing CME Group's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://www.benzinga.com/pro/">Benzinga Pro</a>, CME Group's peer group average for short interest as a percentage of float is 3.51%, which means the company has less short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

Short Sellers

How Do Investors Really Feel About CME Group?

Solana (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/sol/usd">SOL</a>) futures have started trading on the <a href="https://www.benzinga.com/insights/analyst-ratings/25/03/44221065/a-glimpse-into-the-expert-outlook-on-cme-group-through-12-analysts">Chicago Mercantile Exchange</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CME#NASDAQ">CME</a>) this week, but early activity was underwhelming compared to major cryptocurrencies like Bitcoin and Ethereum.
According to a report by research firm K33, the first day of trading for Solana futures saw a total volume of $12.3 million, with open interest ending at $7.8 million.
This marked a stark contrast to Bitcoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>) futures, which drew $102.7 million in volume and $20.9 million in open interest during their December 2017 debut on CME. 
Ethereum (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/eth/usd">ETH</a>) fared better too, recording $31 million in trading and $20 million in open interest when its futures launched in February 2021.
K33 analysts Vetle Lunde and David Zimmerman <a href="https://k33.com/research/articles/stabilizing-flow-stabilizing-market">attributed</a> the tepid performance to broader market conditions, noting that Solana's introduction came during a period of muted risk appetite and without the tailwinds of a strong bull market or a rally in alternative cryptocurrencies.
Also Read: <a href="https://www.benzinga.com/markets/cryptocurrency/25/03/44380265/bitcoin-is-past-the-bull-cycle-peak-top-analyst-warns">Bitcoin Is &#8216;Past The Bull Cycle Peak,&#8217; Top Analyst Warns</a>
&#8220;Although Solana&#8217;s performance appears more reasonable when adjusted for its market capitalization, its absolute figures were far lower than previous futures launches,&#8221; the K33 report stated.
The analysts added that despite the subdued start, the listing does fit a pattern often associated with eventual spot ETF approvals. 
However, they cautioned that Solana's lower trading activity suggests any future ETF tied to the token may have a more modest impact on prices compared to the rally sparked by Bitcoin's spot ETF approval in early 2024.
What&#8217;s Next: The report comes at a time when several altcoin ETFs, including those for Solana, are under review by U.S. regulators.
For now, the futures market signals that institutional demand for Solana has yet to match the enthusiasm seen for Bitcoin and Ethereum during their initial futures rollouts.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/markets/cryptocurrency/25/03/44378673/strategy-announces-500-million-strf-preferred-stock-offering-to-boost-bitcoin-investments">Strategy Announces $500 Million STRF Preferred Stock Offering To Boost Bitcoin Investments</a></li>
</ul>
Image: Shutterstock

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

$BTC

$ETH

$SOL

Solana Underperforms Historical Bitcoin, Ethereum Volumes On First Day Of CME Futures Trading

This whale alert can help traders discover the next big trading opportunities.
Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity scanner.
Traders will search for circumstances when the market estimation of an option diverges heavily from its normal worth. High amounts of trading activity could push option prices to exaggerated or underestimated levels. 
Below are some instances of options activity happening in the Financials sector: 
<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th>Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>GS</td>
<td>PUT</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>05/16/25</td>
<td>$555.00</td>
<td>$123.8K</td>
<td>23</td>
<td>1.3K</td>
</tr>
<tr>
<td>C</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>04/17/25</td>
<td>$67.50</td>
<td>$125.6K</td>
<td>4.6K</td>
<td>869</td>
</tr>
<tr>
<td>V</td>
<td>CALL</td>
<td>TRADE</td>
<td>NEUTRAL</td>
<td>03/21/25</td>
<td>$335.00</td>
<td>$158.4K</td>
<td>1.4K</td>
<td>839</td>
</tr>
<tr>
<td>MA</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>05/16/25</td>
<td>$540.00</td>
<td>$122.7K</td>
<td>504</td>
<td>725</td>
</tr>
<tr>
<td>JPM</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>01/16/26</td>
<td>$330.00</td>
<td>$68.9K</td>
<td>786</td>
<td>500</td>
</tr>
<tr>
<td>HOOD</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>01/15/27</td>
<td>$40.00</td>
<td>$29.0K</td>
<td>4.9K</td>
<td>492</td>
</tr>
<tr>
<td>AFRM</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>03/28/25</td>
<td>$45.00</td>
<td>$46.9K</td>
<td>602</td>
<td>445</td>
</tr>
<tr>
<td>CME</td>
<td>PUT</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>09/19/25</td>
<td>$260.00</td>
<td>$117.0K</td>
<td>1.0K</td>
<td>400</td>
</tr>
<tr>
<td>MET</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>12/17/27</td>
<td>$55.00</td>
<td>$31.6K</td>
<td>400</td>
<td>62</td>
</tr>
<tr>
<td>COIN</td>
<td>PUT</td>
<td>TRADE</td>
<td>NEUTRAL</td>
<td>03/21/25</td>
<td>$227.50</td>
<td>$36.1K</td>
<td>18</td>
<td>19</td>
</tr>
</tbody>
</table>

<h2>Explanation</h2>
These bullet-by-bullet explanations have been constructed using the accompanying table. 
• Regarding GS (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GS#NYSE">GS</a>), we observe a put option trade with bullish sentiment. It expires in 59 day(s) on May 16, 2025. Parties traded 40 contract(s) at a $555.00 strike. The total cost received by the writing party (or parties) was $123.8K, with a price of $3095.0 per contract. There were 23 open contracts at this strike prior to today, and today 1323 contract(s) were bought and sold. 
• For C (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/C#NYSE">C</a>), we notice a put option sweep that happens to be bullish, expiring in 30 day(s) on April 17, 2025. This event was a transfer of 748 contract(s) at a $67.50 strike. This particular put needed to be split into 7 different trades to become filled. The total cost received by the writing party (or parties) was $125.6K, with a price of $168.0 per contract. There were 4664 open contracts at this strike prior to today, and today 869 contract(s) were bought and sold. 
• For V (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/V#NYSE">V</a>), we notice a call option trade that happens to be neutral, expiring in 3 day(s) on March 21, 2025. This event was a transfer of 600 contract(s) at a $335.00 strike. The total cost received by the writing party (or parties) was $158.4K, with a price of $264.0 per contract. There were 1486 open contracts at this strike prior to today, and today 839 contract(s) were bought and sold. 
• Regarding MA (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MA#NYSE">MA</a>), we observe a put option sweep with bullish sentiment. It expires in 59 day(s) on May 16, 2025. Parties traded 50 contract(s) at a $540.00 strike. This particular put needed to be split into 3 different trades to become filled. The total cost received by the writing party (or parties) was $122.7K, with a price of $2455.0 per contract. There were 504 open contracts at this strike prior to today, and today 725 contract(s) were bought and sold. 
• For JPM (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/JPM#NYSE">JPM</a>), we notice a call option sweep that happens to be bullish, expiring in 304 day(s) on January 16, 2026. This event was a transfer of 428 contract(s) at a $330.00 strike. This particular call needed to be split into 12 different trades to become filled. The total cost received by the writing party (or parties) was $68.9K, with a price of $161.0 per contract. There were 786 open contracts at this strike prior to today, and today 500 contract(s) were bought and sold. 
• Regarding HOOD (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HOOD#NASDAQ">HOOD</a>), we observe a call option trade with bullish sentiment. It expires in 668 day(s) on January 15, 2027. Parties traded 19 contract(s) at a $40.00 strike. The total cost received by the writing party (or parties) was $29.0K, with a price of $1530.0 per contract. There were 4941 open contracts at this strike prior to today, and today 492 contract(s) were bought and sold. 
• For AFRM (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AFRM#NASDAQ">AFRM</a>), we notice a call option trade that happens to be bearish, expiring in 10 day(s) on March 28, 2025. This event was a transfer of 241 contract(s) at a $45.00 strike. The total cost received by the writing party (or parties) was $46.9K, with a price of $195.0 per contract. There were 602 open contracts at this strike prior to today, and today 445 contract(s) were bought and sold. 
• For CME (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CME#NASDAQ">CME</a>), we notice a put option trade that happens to be bearish, expiring in 185 day(s) on September 19, 2025. This event was a transfer of 100 contract(s) at a $260.00 strike. The total cost received by the writing party (or parties) was $117.0K, with a price of $1170.0 per contract. There were 1043 open contracts at this strike prior to today, and today 400 contract(s) were bought and sold. 
• For MET (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MET#NYSE">MET</a>), we notice a call option trade that happens to be bullish, expiring in 1004 day(s) on December 17, 2027. This event was a transfer of 10 contract(s) at a $55.00 strike. The total cost received by the writing party (or parties) was $31.6K, with a price of $3160.0 per contract. There were 400 open contracts at this strike prior to today, and today 62 contract(s) were bought and sold. 
• For COIN (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/COIN#NASDAQ">COIN</a>), we notice a put option trade that happens to be neutral, expiring in 3 day(s) on March 21, 2025. This event was a transfer of 8 contract(s) at a $227.50 strike. The total cost received by the writing party (or parties) was $36.1K, with a price of $4523.0 per contract. There were 18 open contracts at this strike prior to today, and today 19 contract(s) were bought and sold. 
Options Alert Terminology 
 - Call Contracts: The right to buy shares as indicated in the contract. 
 - Put Contracts: The right to sell shares as indicated in the contract. 
 - Expiration Date: When the contract expires. One must act on the contract by this date if one wants to use it. 
 - Premium/Option Price: The price of the contract. 
For more information, visit our <a href="https://pro.benzinga.com/blog/how-to-understand-option-alerts/">Guide to Understanding Options Alerts</a> or read <a href="https://www.benzinga.com/markets/options">more news on unusual options activity</a>. 
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Options

AFRM

COIN

HOOD

10 Financials Stocks With Whale Alerts In Today's Session

This whale alert can help traders discover the next big trading opportunities.
Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity scanner.
Traders often look for circumstances when the market estimation of an option diverges away from its normal worth. Abnormal amounts of trading activity could push option prices to hyperbolic or underperforming levels. 
Here's the list of options activity happening in today's session: 
<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th>Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>HOOD</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>03/21/25</td>
<td>$40.00</td>
<td>$27.0K</td>
<td>19.6K</td>
<td>12.0K</td>
</tr>
<tr>
<td>BAC</td>
<td>CALL</td>
<td>TRADE</td>
<td>NEUTRAL</td>
<td>03/21/25</td>
<td>$41.00</td>
<td>$43.0K</td>
<td>10.4K</td>
<td>3.1K</td>
</tr>
<tr>
<td>SOFI</td>
<td>PUT</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>03/28/25</td>
<td>$11.00</td>
<td>$25.6K</td>
<td>3.9K</td>
<td>2.6K</td>
</tr>
<tr>
<td>CME</td>
<td>PUT</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>09/19/25</td>
<td>$260.00</td>
<td>$104.4K</td>
<td>479</td>
<td>684</td>
</tr>
<tr>
<td>AFRM</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>03/28/25</td>
<td>$45.00</td>
<td>$34.9K</td>
<td>123</td>
<td>603</td>
</tr>
<tr>
<td>C</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>05/16/25</td>
<td>$70.00</td>
<td>$73.0K</td>
<td>1.5K</td>
<td>445</td>
</tr>
<tr>
<td>UPST</td>
<td>CALL</td>
<td>TRADE</td>
<td>NEUTRAL</td>
<td>04/11/25</td>
<td>$55.00</td>
<td>$28.5K</td>
<td>128</td>
<td>325</td>
</tr>
<tr>
<td>XYZ</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>09/19/25</td>
<td>$47.50</td>
<td>$76.7K</td>
<td>1.7K</td>
<td>216</td>
</tr>
<tr>
<td>GS</td>
<td>PUT</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>03/21/25</td>
<td>$550.00</td>
<td>$25.4K</td>
<td>1.1K</td>
<td>114</td>
</tr>
<tr>
<td>MCO</td>
<td>PUT</td>
<td>SWEEP</td>
<td>NEUTRAL</td>
<td>04/17/25</td>
<td>$450.00</td>
<td>$34.0K</td>
<td>54</td>
<td>86</td>
</tr>
</tbody>
</table>

<h2>Explanation</h2>
These bullet-by-bullet explanations have been constructed using the accompanying table. 
• Regarding HOOD (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HOOD#NASDAQ">HOOD</a>), we observe a call option sweep with bearish sentiment. It expires in 4 day(s) on March 21, 2025. Parties traded 100 contract(s) at a $40.00 strike. This particular call needed to be split into 7 different trades to become filled. The total cost received by the writing party (or parties) was $27.0K, with a price of $270.0 per contract. There were 19685 open contracts at this strike prior to today, and today 12007 contract(s) were bought and sold. 
• Regarding BAC (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BAC#NYSE">BAC</a>), we observe a call option trade with neutral sentiment. It expires in 4 day(s) on March 21, 2025. Parties traded 500 contract(s) at a $41.00 strike. The total cost received by the writing party (or parties) was $43.0K, with a price of $86.0 per contract. There were 10410 open contracts at this strike prior to today, and today 3104 contract(s) were bought and sold. 
• For SOFI (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SOFI#NASDAQ">SOFI</a>), we notice a put option trade that happens to be bearish, expiring in 11 day(s) on March 28, 2025. This event was a transfer of 1600 contract(s) at a $11.00 strike. The total cost received by the writing party (or parties) was $25.6K, with a price of $16.0 per contract. There were 3974 open contracts at this strike prior to today, and today 2660 contract(s) were bought and sold. 
• For CME (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CME#NASDAQ">CME</a>), we notice a put option trade that happens to be bearish, expiring in 186 day(s) on September 19, 2025. This event was a transfer of 81 contract(s) at a $260.00 strike. The total cost received by the writing party (or parties) was $104.4K, with a price of $1290.0 per contract. There were 479 open contracts at this strike prior to today, and today 684 contract(s) were bought and sold. 
• Regarding AFRM (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AFRM#NASDAQ">AFRM</a>), we observe a put option sweep with bearish sentiment. It expires in 11 day(s) on March 28, 2025. Parties traded 167 contract(s) at a $45.00 strike. This particular put needed to be split into 3 different trades to become filled. The total cost received by the writing party (or parties) was $34.9K, with a price of $209.0 per contract. There were 123 open contracts at this strike prior to today, and today 603 contract(s) were bought and sold. 
• Regarding C (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/C#NYSE">C</a>), we observe a call option trade with bullish sentiment. It expires in 60 day(s) on May 16, 2025. Parties traded 200 contract(s) at a $70.00 strike. The total cost received by the writing party (or parties) was $73.0K, with a price of $365.0 per contract. There were 1569 open contracts at this strike prior to today, and today 445 contract(s) were bought and sold. 
• Regarding UPST (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/UPST#NASDAQ">UPST</a>), we observe a call option trade with neutral sentiment. It expires in 25 day(s) on April 11, 2025. Parties traded 100 contract(s) at a $55.00 strike. The total cost received by the writing party (or parties) was $28.5K, with a price of $285.0 per contract. There were 128 open contracts at this strike prior to today, and today 325 contract(s) were bought and sold. 
• Regarding XYZ (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XYZ#NYSE">XYZ</a>), we observe a put option sweep with bullish sentiment. It expires in 186 day(s) on September 19, 2025. Parties traded 216 contract(s) at a $47.50 strike. This particular put needed to be split into 9 different trades to become filled. The total cost received by the writing party (or parties) was $76.7K, with a price of $355.0 per contract. There were 1740 open contracts at this strike prior to today, and today 216 contract(s) were bought and sold. 
• Regarding GS (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GS#NYSE">GS</a>), we observe a put option trade with bearish sentiment. It expires in 4 day(s) on March 21, 2025. Parties traded 33 contract(s) at a $550.00 strike. The total cost received by the writing party (or parties) was $25.4K, with a price of $770.0 per contract. There were 1167 open contracts at this strike prior to today, and today 114 contract(s) were bought and sold. 
• Regarding MCO (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MCO#NYSE">MCO</a>), we observe a put option sweep with neutral sentiment. It expires in 31 day(s) on April 17, 2025. Parties traded 31 contract(s) at a $450.00 strike. This particular put needed to be split into 20 different trades to become filled. The total cost received by the writing party (or parties) was $34.0K, with a price of $1140.0 per contract. There were 54 open contracts at this strike prior to today, and today 86 contract(s) were bought and sold. 
Options Alert Terminology 
 - Call Contracts: The right to buy shares as indicated in the contract. 
 - Put Contracts: The right to sell shares as indicated in the contract. 
 - Expiration Date: When the contract expires. One must act on the contract by this date if one wants to use it. 
 - Premium/Option Price: The price of the contract. 
For more information, visit our <a href="https://pro.benzinga.com/blog/how-to-understand-option-alerts/">Guide to Understanding Options Alerts</a> or read <a href="https://www.benzinga.com/markets/options">more news on unusual options activity</a>. 
This article was generated by Benzinga's automated content engine and reviewed by an editor.

SOFI

UPST

CNBC Halftime Report Final Trades: Delta Air Lines, Exxon Mobil, Gap, CME Group

In the preceding three months, 12 analysts have released ratings for CME Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CME#NASDAQ">CME</a>), presenting a wide array of perspectives from bullish to bearish.
The following table provides a quick overview of their recent ratings, highlighting the changing sentiments over the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">0</td>
<td align="right">3</td>
<td align="right">8</td>
<td align="right">1</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">4</td>
<td align="right">1</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">3</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
Analysts' evaluations of 12-month price targets offer additional insights, showcasing an average target of $256.58, with a high estimate of $287.00 and a low estimate of $212.00. This current average has increased by 4.22% from the previous average price target of $246.18. 
<img src="https://www.benzinga.com/files/images/story/2025/1741616044_0.png" alt="price target chart" />
<h2>Analyzing Analyst Ratings: A Detailed Breakdown</h2>
The standing of CME Group among financial experts becomes clear with a thorough analysis of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Patrick O'Shaughnessy</td>
<td>Raymond James</td>
<td>Announces</td>
<td>Outperform</td>
<td>$287.00</td>
<td>-</td>
</tr>
<tr>
<td>Mike Cyprys</td>
<td>Morgan Stanley</td>
<td>Raises</td>
<td>Equal-Weight</td>
<td>$263.00</td>
<td>$256.00</td>
</tr>
<tr>
<td>Kyle Voigt</td>
<td>Keefe, Bruyette &amp; Woods</td>
<td>Raises</td>
<td>Market Perform</td>
<td>$257.00</td>
<td>$256.00</td>
</tr>
<tr>
<td>Ashish Sabadra</td>
<td>RBC Capital</td>
<td>Raises</td>
<td>Sector Perform</td>
<td>$269.00</td>
<td>$235.00</td>
</tr>
<tr>
<td>Owen Lau</td>
<td>Oppenheimer</td>
<td>Raises</td>
<td>Outperform</td>
<td>$269.00</td>
<td>$258.00</td>
</tr>
<tr>
<td>Kenneth Worthington</td>
<td>JP Morgan</td>
<td>Raises</td>
<td>Underweight</td>
<td>$212.00</td>
<td>$209.00</td>
</tr>
<tr>
<td>Benjamin Budish</td>
<td>Barclays</td>
<td>Raises</td>
<td>Equal-Weight</td>
<td>$263.00</td>
<td>$257.00</td>
</tr>
<tr>
<td>Kyle Voigt</td>
<td>Keefe, Bruyette &amp; Woods</td>
<td>Lowers</td>
<td>Market Perform</td>
<td>$256.00</td>
<td>$260.00</td>
</tr>
<tr>
<td>Patrick Moley</td>
<td>Piper Sandler</td>
<td>Raises</td>
<td>Overweight</td>
<td>$258.00</td>
<td>$250.00</td>
</tr>
<tr>
<td>Ashish Sabadra</td>
<td>RBC Capital</td>
<td>Maintains</td>
<td>Sector Perform</td>
<td>$235.00</td>
<td>$235.00</td>
</tr>
<tr>
<td>Christopher Allen</td>
<td>Citigroup</td>
<td>Lowers</td>
<td>Neutral</td>
<td>$250.00</td>
<td>$255.00</td>
</tr>
<tr>
<td>Kyle Voigt</td>
<td>Keefe, Bruyette &amp; Woods</td>
<td>Raises</td>
<td>Market Perform</td>
<td>$260.00</td>
<td>$237.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Analysts respond to changes in market conditions and company performance, frequently updating their recommendations. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to CME Group. This information offers a snapshot of how analysts perceive the current state of the company.</li>
<li>Rating: Offering insights into predictions, analysts assign qualitative values, from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of CME Group compared to the broader market.</li>
<li>Price Targets: Analysts navigate through adjustments in price targets, providing estimates for CME Group's future value. Comparing current and prior targets offers insights into analysts' evolving expectations.</li>
</ul>
To gain a panoramic view of CME Group's market performance, explore these analyst evaluations alongside essential financial indicators. Stay informed and make judicious decisions using our Ratings Table.
<a href="https://www.benzinga.com/quote/CME/analyst-ratings?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Stay up to date on CME Group analyst ratings.</a>
<h2>About CME Group</h2>
Based in Chicago, CME Group operates exchanges giving investors, suppliers, and businesses the ability to trade futures and derivatives based on interest rates, equity indexes, foreign currencies, energy, metals, and commodities. The Chicago Mercantile Exchange was founded in 1898 and in 2002 completed its IPO. Since then, CME Group has consolidated parts of the industry by merging with crosstown rival CBOT Holdings in 2007 before acquiring Nymex Holdings in 2008 and NEX in 2018. In addition, the company has a 27% stake in S&amp;P Dow Jones Indices, making the Chicago Mercantile Exchange the exclusive venue to trade and clear S&amp;P futures contracts. Through CME's acquisition of NEX, it also expanded into cash foreign exchange, fixed-income trading, and collateral optimization.
<h3>CME Group: Delving into Financials</h3>
Market Capitalization: Surpassing industry standards, the company's market capitalization asserts its dominance in terms of size, suggesting a robust market position.
Positive Revenue Trend: Examining CME Group's financials over 3 months reveals a positive narrative. The company achieved a noteworthy revenue growth rate of 5.98% as of 31 December, 2024, showcasing a substantial increase in top-line earnings. When compared to others in the Financials sector, the company faces challenges, achieving a growth rate lower than the average among peers.
Net Margin: The company's net margin is a standout performer, exceeding industry averages. With an impressive net margin of 56.62%, the company showcases strong profitability and effective cost control.
Return on Equity (ROE): CME Group's ROE stands out, surpassing industry averages. With an impressive ROE of 3.16%, the company demonstrates effective use of equity capital and strong financial performance.
Return on Assets (ROA): The company's ROA is below industry benchmarks, signaling potential difficulties in efficiently utilizing assets. With an ROA of 0.63%, the company may need to address challenges in generating satisfactory returns from its assets.
Debt Management: CME Group's debt-to-equity ratio is below the industry average at 0.13, reflecting a lower dependency on debt financing and a more conservative financial approach.
<h2>How Are Analyst Ratings Determined?</h2>
Analysts are specialists within banking and financial systems that typically report for specific stocks or within defined sectors. These people research company financial statements, sit in conference calls and meetings, and speak with relevant insiders to determine what are known as analyst ratings for stocks. Typically, analysts will rate each stock once a quarter. 
Some analysts publish their predictions for metrics such as growth estimates, earnings, and revenue to provide additional guidance with their ratings. When using analyst ratings, it is important to keep in mind that stock and sector analysts are also human and are only offering their opinions to investors.
Breaking: Wall Street's Next Big Mover
Benzinga's #1 analyst just identified a stock poised for explosive growth. This under-the-radar company could surge 200%+ as major market shifts unfold. <a href="https://www.benzinga.com/premium/ideas/turning-point-trader-checkout-2/?t=Tu1tu3arja3be22tu36&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantag">Click here for urgent details</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

A Glimpse Into The Expert Outlook On CME Group Through 12 Analysts

Raymond James analyst Patrick O'Shaughnessy upgrades CME Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CME#NASDAQ">CME</a>) from Market Perform to Outperform and announces $287 price target.

Upgrades

Raymond James Upgrades CME Group to Outperform, Announces $287 Price Target

CME Group Financial Settled Options On Bitcoin Friday Futures Are Available For Trading

Morgan Stanley analyst Mike Cyprys maintains CME Gr (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CME#NASDAQ">CME</a>) with a Equal-Weight and raises the price target from $256 to $263.

Morgan Stanley Maintains Equal-Weight on CME Gr, Raises Price Target to $263

On CNBC's &#8220;<a href="https://www.cnbc.com/video/2025/02/14/final-trades-toast-cme-group-goldman-sachs-and-diamondback-energy.html">Halftime Report Final Trades</a>,&#8221; Joshua Brown of Ritholtz Wealth Management named Toast, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TOST#NYSE">TOST</a>) as his <a href="https://www.benzinga.com/quote/TOST/analyst-ratings">final trade</a>.
Supporting his view, Oppenheimer analyst Rayna Kumar, on Jan. 24, initiated coverage on Toast with an Outperform rating and announced a price target of $46. Toast, meanwhile, will release financial results for the fourth quarter and full year following the close of markets on Wednesday, Feb. 19.
Kevin Simpson of Capital Wealth Planning picked CME Group Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CME#NASDAQ">CME</a>).
Adding support to his choice, CME, on Feb. 12, posted better-than-expected results for the fourth quarter. The company posted adjusted earnings of $2.52 per share, beating market estimates of $2.44 per share. Its sales came in at $1.525 billion versus expectations of $1.519 billion.
Don't forget to check out our <a href="https://www.benzinga.com/premarket/">premarket coverage here</a>
Rounding out the trades, Jason Snipe of Odyssey Capital Advisors named Goldman Sachs Group, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GS#NYSE">GS</a>).
According to a latest 13F filing with the SEC, Goldman Sachs loaded up more shares of Bitcoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>) and Ethereum (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/eth/usd">ETH</a>) spot exchange-traded funds in the fourth quarter of 2024. The Wall Street giant reported a significant stake in Fidelity Wise Origin Bitcoin Fund (BATS:<a class="ticker" href="https://www.benzinga.com/stock/FBTC#BATS">FBTC</a>), with 3.53 million shares valued at $288.01 million. Goldman Sachs bought an additional 1.8 million shares of FBTC in the fourth quarter ending Dec. 31.
Price Action:
<ul>
<li>Toast shares gained 0.7% to close at $40.49 on Friday.</li>
<li>CME fell 1.9% to settle at $245.48 during Friday's session.</li>
<li>Goldman Sachs shares gained 1.8% to close at $660.55 on Friday.</li>
</ul>
Check This Out: 
<ul>
<li><a href="https://www.benzinga.com/trading-ideas/short-ideas/25/02/43730195/top-3-defensive-stocks-that-may-collapse-in-q1">Top 3 Defensive Stocks That May Collapse In Q1</a></li>
</ul>
Image: Shutterstock

Long Ideas

Media

Fidelity Wise Origin Bitcoin Fund Fidelity Wise Origin Bitcoin Fund

FBTC

TOST

Toast, CME Group And An Investment Bank On CNBC's 'Final Trades'

FANG

CNBC Halftime Report Final Trades: Toast, CME Group, The Goldman Sachs Group, Diamondback Energy

Keefe, Bruyette &amp; Woods analyst Kyle Voigt maintains CME Gr (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CME#NASDAQ">CME</a>) with a Market Perform and raises the price target from $256 to $257.

Keefe, Bruyette & Woods Maintains Market Perform on CME Gr, Raises Price Target to $257

RBC Capital analyst Ashish Sabadra maintains CME Gr (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CME#NASDAQ">CME</a>) with a Sector Perform and raises the price target from $235 to $269.

RBC Capital Maintains Sector Perform on CME Gr, Raises Price Target to $269

Oppenheimer analyst Owen Lau maintains CME Gr (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CME#NASDAQ">CME</a>) with a Outperform and raises the price target from $258 to $269.

Oppenheimer Maintains Outperform on CME Gr, Raises Price Target to $269

Press Releases

BrokerTec Sets New Single-Day Volume Record With Over $1 Trillion Notional Traded

CME Group to Launch Bloomberg Commodity (BCOM) Subindex Futures on March 31

CME Group Inc. Announces First-Quarter 2025 Earnings Release, Conference Call

Contracts

CME Group Expands Credit Products with High Yield Duration-Hedged Futures

CME Group Announces First Trades of Solana (SOL) Futures

CME Group to Launch BrokerTec U.S. Treasury Central Limit Order Book in Chicago to Streamline Trading Between Cash and Futures Markets

Fintech

CME Group Will Introduce Tokenization Technology to Enhance Capital Market Efficiency Using Google Cloud's New Universal Ledger

Producer sentiment slips due to rising policy uncertainty

CME Group Sets New, All-Time Quarterly ADV Record of 29.8 Million Contracts, Driven by Growth Across All Asset Classes

CME Group to Launch Spot-Quoted Futures, Providing Innovative New Trading Opportunities for Retail Investors

AGM Group Holdings Inc. - Class A Ordinary Shares

AGM Gr Hldgs

Bakkt Holdings, Inc. Class A Common Stock

Bakkt Hldgs

Coincheck Group

Coinbase Global, Inc. - Class A Common Stock

Coinbase Global

Donnelley Financial Solutions, Inc. Common Stock

Donnelley Financial Solns

FactSet Research Systems Inc. Common Stock

FactSet Research Systems

Fold Holdings, Inc. - Class A Common Stock

Fold Holdings

Intercontinental Exchange Inc. Common Stock

Intercontinental Exchange

Open Lending

Moodys

Marketwise

MarketAxess Holdings, Inc. - Common Stock

MarketAxess Holdings

Morningstar

MSCI

Nasdaq

Powell Max Limited - Class A Ordinary Shares

Powell Max

S&P Global

Tradeweb Markets Inc. - Class A Common Stock

Comments

CME Group

뉴스

파트너 / 기고자

벤징가 글로벌